Spain-based biopharmaceutical company PharmaMar sees its drug Yondelis approved in the European Union.
6 reports, 2 independent
Updated Sep 12
Gone quiet
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Spain-based biopharmaceutical company PharmaMar sees its drug Yondelis approved in the European Union.